HSP90AB1 and cancer: However, Hsp90 continues to represent an interesting cancer drug target, and further novel lead molecules are needed to identify non‐cytotoxic Hsp90 inhibitors for the benefit of cancer patients, especially within combination therapy regimes alongside chemotherapy and/or targeted therapy.